CXCR4 and bone metastasis: reported that the bone metastasis rate of CXCR4-positive CTCs in neuroendocrine tumor patients was 56% compared to 35% in patients without bone metastasis (p = 0.18),which may be involved in CTC osteotropism and predicting the bone metastasis (52).